STOCK TITAN

Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Guardant Health, Inc. will report Q3 2023 financial results on November 6, 2023.
Positive
  • Guardant Health, Inc. will report its Q3 2023 financial results after market close on November 6, 2023.
Negative
  • None.

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will report financial results for the third quarter of 2023 after market close on Monday, November 6, 2023. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast will be archived and available for replay after the event.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY® tests for advanced stage cancer, and Guardant Reveal™ for early-stage cancer. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening. For more information, visit guardanthealth.com and follow the company on LinkedIn and X (Twitter).

Source: Guardant Health, Inc.

Investor Contact:

investors@guardanthealth.com

Media Contact:

Melissa Marasco

press@guardanthealth.com

+1 650-647-3711

Source: Guardant Health, Inc.

FAQ

When will Guardant Health, Inc. report its Q3 2023 financial results?

Guardant Health, Inc. will report its Q3 2023 financial results on November 6, 2023.

What time will the conference call begin?

The conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Where can I listen to the webcast?

You can listen to the webcast on the “Investors” section of the company website at www.guardanthealth.com.

Will the webcast be available for replay?

Yes, the webcast will be archived and available for replay after the event.

Guardant Health, Inc.

NASDAQ:GH

GH Rankings

GH Latest News

GH Stock Data

2.23B
116.64M
4.15%
92.14%
6.28%
Dental Laboratories
Manufacturing
Link
United States of America
PALO ALTO

About GH

we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.